Page last updated: 2024-08-21

adamantane and Atheroma

adamantane has been researched along with Atheroma in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (75.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Chen, Q; Gao, C; Kwong, CHT; Lee, SMY; Liu, C; Wang, Q; Wang, R; Wang, Y; Xie, B1
Liu, YS; Lu, QH; Zhang, J1
Ametamey, SM; Borel, N; Krämer, SD; Meletta, R; Mu, L; Müller Herde, A; Rancic, Z; Schibli, R; Slavik, R1
Hirano, T; Miyazaki, A; Mori, Y; Nagashima, M; Nohtomi, K; Terasaki, M; Watanabe, T1

Other Studies

4 other study(ies) available for adamantane and Atheroma

ArticleYear
Cyclodextrin-mediated conjugation of macrophage and liposomes for treatment of atherosclerosis.
    Journal of controlled release : official journal of the Controlled Release Society, 2022, Volume: 349

    Topics: Adamantane; Animals; Atherosclerosis; beta-Cyclodextrins; Cholesterol; Cyclodextrins; Humans; Inflammation; Liposomes; Liver X Receptors; Macrophages; Mice; NF-E2-Related Factor 2; Plaque, Atherosclerotic; Quercetin

2022
Therapeutic effects of the soluble epoxide hydrolase (sEH) inhibitor AUDA on atherosclerotic diseases.
    Die Pharmazie, 2015, Volume: 70, Issue:1

    Topics: Adamantane; Animals; Aorta, Thoracic; Apolipoproteins E; Atherosclerosis; Cytokines; Enzyme Inhibitors; Epoxide Hydrolases; In Vitro Techniques; Lauric Acids; Mice; Mice, Knockout; NF-kappa B; Plaque, Atherosclerotic; Toll-Like Receptor 4

2015
Cannabinoid receptor type 2 (CB2) as one of the candidate genes in human carotid plaque imaging: Evaluation of the novel radiotracer [
    Nuclear medicine and biology, 2017, Volume: 47

    Topics: Adamantane; Animals; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Biomarkers; Carbon Radioisotopes; Carotid Artery Diseases; Gene Expression Regulation; Humans; Male; Mice; Plaque, Atherosclerotic; Positron Emission Tomography Computed Tomography; Quinolones; Radioactive Tracers; Receptor, Cannabinoid, CB2

2017
Effects of PKF275-055, a dipeptidyl peptidase-4 inhibitor, on the development of atherosclerotic lesions in apolipoprotein E-null mice.
    Metabolism: clinical and experimental, 2012, Volume: 61, Issue:7

    Topics: Adamantane; Animals; Apolipoproteins E; Atherosclerosis; Cholesterol; Diet, Atherogenic; Dipeptidyl-Peptidase IV Inhibitors; Foam Cells; Gastric Inhibitory Polypeptide; Glucagon-Like Peptide 1; Lipoproteins, LDL; Male; Mice; Nitriles; Plaque, Atherosclerotic; Pyrrolidines; Weight Loss

2012